Neurorehabilitation News

CHICAGO — Impairments in decision-making may be among the earliest signs of cognitive decline, according to a presenter at the 2022 American Neurological Association annual meeting.

CHICAGO — Low-income and underrepresented populations are at greater risk for neurodevelopmental effects related to chemical exposures, according to an expert at the 2022 American Neurological Association annual meeting.

CHICAGO — Igor J. Koralnik, MD, discusses highlights from his presentation at the 2022 American Neurological Association’s annual meeting on long COVID and its effect on the nervous system.

CHICAGO — Older age at symptom onset and select pathologies were associated with shorter symptom duration in patients with rapidly progressive dementia, according to a poster at ANA 2022.

CHICAGO — Environmental chemical exposure is a risk factor for neurodegenerative diseases and neurodevelopmental disorders, an expert at the 2022 American Neurological Association annual meeting said.

CHICAGO — While population and phenotypic diversity are crucial to discovering the root cause of genetic variations that lead to neurodegenerative disease, the answers are not always clear, according to a presenter at ANA 2022.

CHICAGO – An app-based cognitive assessment tool set baseline scores for college football players and may be useful in rapid sideline concussion diagnosis, according to a poster at the 2022 American Neurological Association meeting.

CHICAGO — Persistent neurocognitive impairment, depression and anxiety were frequently reported in individuals with mild COVID-19 infection in Lima, Peru, according to a poster at ANA 2022.

CHICAGO — For older adults who experience first-time stroke, approaching recovery with optimism improves functional recovery, according to a poster at the American Neurological Association annual meeting.

CHICAGO – Jennifer A. Frontera, MD, professor of neurology at NYU School of Medicine, discussed possible therapeutic strategies for those with long COVID who are experiencing neurological symptoms at ANA 2022.